title: The acute effect of an oral "inotropic" placebo on the exercise capacity of patients with chronic cardiac failure.
abstract: Uncontrolled studies have suggested that the newer oral phosphodiesterase inhibitors milrinone and enoximone acutely improve exercise performance in patients with severe chronic cardiac failure. To determine whether an oral placebo presented as an inotropic agent could acutely enhance exercise capacity, two separate groups of stable heart failure patients were studied by serial exercise testing and respiratory gas exchange analysis. Group 1 had nine patients studied four hours after a single oral dose of placebo, and group 2 had ten patients retested after one to two weeks of placebo therapy. No significant change was seen in the mean exercise time, mean peak oxygen consumption, and the mean oxygen consumption at anaerobic threshold after placebo administration in both group 1 and group 2 patients. Improvements in exercise time, peak oxygen consumption, and oxygen consumption at anaerobic threshold occurred in five patients in group 1 and seven patients in group 2. The improvements exceeded the baseline variability of 10 percent in three group 1 patients. Among group 2 patients, the increase in exercise time, peak oxygen consumption, and oxygen consumption at anaerobic threshold exceeded 10 percent in six, four, and four patients, respectively. Thus, stable chronic heart failure patients can achieve a true baseline exercise capacity. Small improvements in exercise performance seen acutely after oral inotropic drug therapy in individual heart failure patients must be interpreted with caution, as they may be due to a placebo effect.
authors.affiliation: University of Pittsburgh, School of Medicine.
authors.forename: S
authors.initials: S
authors.lastname: Murali
authors.forename: B F
authors.initials: BF
authors.lastname: Uretsky
authors.forename: J A
authors.initials: JA
authors.lastname: Kolesar
authors.forename: A M
authors.initials: AM
authors.lastname: Valdes
authors.forename: P S
authors.initials: PS
authors.lastname: Reddy
mesh_terms: D000368:Aged; D002908:Chronic Disease; D004311:Double-Blind Method; D005080:Exercise Test; D005260:Female; D006333:Heart Failure / Q000378:metabolism / Q000503:physiopathology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009200:Myocardial Contraction / Q000187:drug effects*; D010101:Oxygen Consumption; D005082:Physical Exertion; D010919:Placebos; D011897:Random Allocation
chemical_list: D010919:Placebos